Preview

Messenger of ANESTHESIOLOGY AND RESUSCITATION

Advanced search

PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

https://doi.org/10.21292/2078-5658-2019-16-2-75-82

Abstract

The lecture describes the mechanisms of deterioration of respiratory exchange during exacerbation of chronic obstructive pulmonary disease (COPD). It has been demonstrated that the rapid diagnosis and treatment of exacerbations is an important part of COPD management. The restriction of expiratory airflow followed by the increased dynamic pulmonary hyperinflation seems to be the most important pathophysiological mechanism in COPD exacerbation, which has catastrophic consequences for the respiratory system with respect to respiratory mechanics and gas exchange. In some patients, associated disorders of cardiopulmonary interactions also undoubtedly play an important role.

About the Author

S. N. Avdeev
I.M. Sechenov First Moscow State Medical University; Pulmonology Research Institute by the Federal Medical Biological Agency of Russia
Russian Federation

Doctor of Medical Sciences, Professor, Correspondent Member of RAS, Head of Pulmonology Department;

Deputy Director for Research, Head of Clinical Department



References

1. Chuchalin А.G., Аvdeev S.N., Аysanov Z.R. et al. Federal clinical recommendations on diagnostics and treatment of chronic obstructive pulmonary disease. Pulmonoloiya, 2014, no. 3, pp. 15-54. (In Russ.)

2. Aisanov Z., Avdeev S., Arkhipov V. et al. Russian experience of creating clinical COPD guidelines and a clinical decision making algorithm. Internat. J. COPD, 2018, vol. 13, pp. 183-187.

3. Aliverti A., Macklem P.T. How and why exercise is impaired in COPD. Respiration (Herrlisheim), 2001, vol. 68, pp. 229-239.

4. Amoroso P., Wilson S.R., Moxham J. et al. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax, 1993, vol. 48, pp. 882‒885.

5. Andreas S., Anker S.D., Scanlon P.D. et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest, 2005, vol. 128, pp. 3618‒3624.

6. Anthonisen N.R. Hypoxemia and O2 therapy. Am. Rev. Respir. Dis., 1982, vol. 142, pp. 729‒733.

7. Atsou K., Chouaid C., Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med., 2011, vol. 9, pp. 7.

8. Aubier M., Murciano D., Milic-Emili J. et al. Effects of the administration of O2 on ventilation and blood gases, in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am. Rev. Respir. Dis., 1980, vol. 122, pp. 747‒754.

9. Barbera J.A., Roca J., Ferrer A. et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J., 1997, vol. 10, pp. 1285‒1291.

10. Brochard L. Intrinsic (or auto-) PEEP during controlled mechanical ventilation. Intens. Care Med., 2002, vol. 28, pp. 1376-1378.

11. Broseghini C., Brandolese R., Poggi R. et al. Respiratory mechanics during the first day of mechanical ventilation in patients with pulmonary edema and chronic airway obstruction. Am. Rev. Respir. Dis., 1988, vol. 138, pp. 355‒361.

12. Burrows B., Kettel L.J., Niden A.H. et al. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N. Engl. J. Med., 1972, vol. 286, pp. 912-918.

13. Calverley P.M.A., Koulouris N.G. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur. Respir. J., 2005, vol. 25, pp. 186-199.

14. Campbell E.J.M. The J. Burns Amberson Lecture: the management of acute respiratory failure in chronic bronchitis and emphysema. Am. Rev. Respir. Dis., 1967, vol. 96, pp. 626‒639.

15. Cassart M., Pettiaux N., Gevenois P.A. et al. Effect of chronic hyperinflation on diaphragm length and surface area. Am. J. Respir. Crit. Care Med., 1997, vol. 156, pp. 504-508.

16. Cherniack R.M., Cherniack L., Naimark A. Respiration in health and disease. Philadelphia, W.B. Saunders. 1972, pp. 323-324.

17. Connors A.F.Jr., Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risk Treatments). Am. J. Respir. Crit. Care Med., 1996, vol. 154, pp. 959‒967.

18. Сoussa M.L., Guein C., Eissa N.T. et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J. Appl. Physiol., 1993, vol. 75, pp. 1711‒1719.

19. de Leeuw P.W., Dees A. Fluid homeostasis in chronic obstructive lung disease. Eur. Respir. J., suppl. 2003, vol. 46, pp. 33-40.

20. Derenne J.-P., Fleury B., Pariente R. Acute respiratory failure of chronic obstructive pulmonary disease. Amer. Rev. Respir. Dis., 1988, vol. 138, pp. 1006‒1033.

21. Donald K.W. Neurological effects of oxygen. Lancet, 1949, vol. 12, pp. 883‒885.

22. Eldridge F., Gherman C. Studies of oxygen administration in respiratory failure. Ann. Intern. Med., 1968, vol. 68, pp. 569‒578.

23. Ferguson G. Why does the lung hyperinflate? Proc. Am. Thorac. Soc., 2006, vol. 3, pp. 176‒179.

24. Ferguson J.K.W., Roughton F.J.W. The direct chemical estimation of carbamino compounds of CO2 with haemoglobin. J. Physiol., 1934, vol. 83, pp. 68‒102.

25. Fleury B., Murciano D., Talamo C. et al. Work of breathing in patients with chronic obstructive pulmonary disease in acute respiratory failure. Am. Rev. Respir. Dis., 1985, vol. 131, pp. 822‒827.

26. GBD 2015 Mortality and causes of death collaborators: global, regional and national life expectancy, all-causes mortality and cause-specific mortality for 249 causes of death, 1980‒2015: a systematic analysis for the Global burden of disease study 2015. Lancet, 2016, vol. 388, pp. 1459‒1544.

27. Gibson G.J. Pulmonary hyperinflation a clinical overview. Eur. Respir. J., 1996, vol. 9, pp. 2640‒2649.

28. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. The updated 2019 report is available on www.goldcopd.com.

29. Guerin C., Coussa M.L., Eissa N.T. et al. Lung and chest wall mechanics in mechanically ventilated COPD patients. J. Appl. Physiol., 1993, vol. 74, pp. 1570‒1580.

30. Haluszka J., Chartrand D.A., Grassino E. et al. Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Amer. Rev. Respir. Dis., 1990, vol. 141, pp. 1194‒1197.

31. Hanson C.W., Marshall B.E., Frash H.F. et al. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit. Care Med., 1996, vol. 24, pp. 23‒28.

32. Husebo G.R., Bakke P.S., Aanerud M. et al. Predictors of exacerbations in chronic obstructive pulmonary disease – results from the Bergen COPD cohort study. PLoS One, 2014, vol. 9, pp. e109721.

33. Hyatt R.E. The interrelationship of pressure, flow and volume during various respiratory maneuvers in normal and emphysematous patients. Am. Rev. Respir. Dis., 1961, vol. 83, pp. 676-683.

34. Kawagoe Y., Permutt S., Fessler H.E. Hyperinflation with intrinsic PEEP and respiratory muscle blood flow. J. Appl. Physiol., 1994, vol. 77, pp. 2440‒2448.

35. Macklem P.T. Hyperinflation. Am. Rev. Respir. Dis., 1984, vol. 129, pp. 1‒2.

36. Macnee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1994, vol. 150, pp. 833‒852 and 1158‒1168.

37. Milic-Emili J. Dynamic pulmonary hyperinflation and intrinsic PEEP: consequences and management in patients with chronic obstructive pulmonary disease. Rec. Progress Med., 1990, vol. 81, pp. 733‒737.

38. Pepe P.E., Marini J.J. Occult positive end-expiratory pressure in mechanically-ventilated patients with airflow obstruction. Am. Rev. Respir. Dis., 1982, vol. 126, pp. 166‒170.

39. Rodríguez-Roisin R. COPD exacerbations: Management, Thorax, 2006, vol. 61, pp. 535‒544.

40. Rudolph M., Banks R.A., Semple S.J.G. Hypercapnia during oxygen therapy in acute exacerbations of chronic respiratory failure. Lancet, 1977, vol. 2, pp. 483‒486.

41. Self T.H., Patterson S.J., Headley A.S. et al. Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations: focus on oral corticosteroids. Curr. Med. Res. Opin., 2014, vol. 30, pp. 2607‒2615.

42. Similowski T., Derenne J.P., Milic-Emili J. Respiratory mechanics during acute respiratory failure of chronic obstructive pulmonary disease. Bronchodilators and corticosteroids. In: J.-P. Derenne, W. A. Whitelaw, T. Similowski (Eds) Acute respiratory failure in chronic obstructive pulmonary disease Marcel Dekker., Inc. New York. 1995, pp. 23‒46.

43. Tantuci C., Corbeil C., Chasse M. et al. Flow resistance in patients with chronic obstructive pulmonary disease in acute respiratory failure. Am. Rev. Respir. Dis., 1991, vol. 144, pp. 384‒389.

44. Terry A., Traystman R.J., Newball H.H. et al. Collateral ventilation in man. N. Engl. J. Med., 1978, vol. 298, pp. 10‒14.

45. Tokgoz A.F., Gunen H., Agca M. et al. Patient outcome after chronic obstructive pulmonary disease exacerbations requiring noninvasive ventilation during hospitalization. Arch. Bronconeumol., 2016, vol. 52, pp. 470‒476.

46. Torres A., Reyes A., Roca J. et al. Ventilation/perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning. Am. Rev. Respir. Dis., 1989, vol. 140, pp. 1246-1250.

47. West J.B. State of the art: Ventilation-perfusion relationships. Am. Rev. Respir. Dis., 1977, vol. 116, pp. 919-943.

48. WHO: Chronic obstructive pulmonary disease (COPD). 2016, http://www.who.int/topics/chronic_obstructive_pulmonary_disease/en/.

49. Zielinski J., MacNee W., Wedzicha J. et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis., 1997, vol. 52, pp. 43‒47.


Review

For citations:


Avdeev S.N. PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2019;16(2):75-82. (In Russ.) https://doi.org/10.21292/2078-5658-2019-16-2-75-82



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5658 (Print)
ISSN 2541-8653 (Online)